Skip to main content
. 2022 Jan 19;3(4):744–748. doi: 10.34067/KID.0007072021

Figure 1.

Figure 1.

Schematic of a diseased nephron with structural changes associated with diabetes. Binding of finerenone to the mineralocorticoid receptor disrupts transcription of proinflammatory and profibrotic factors. ROS, reactive oxygen species; CTGF, connective tissue growth factor; PAI-1, plasminogen activator inhibitor 1; MMP-2, matrix metalloproteinase 2.